Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17464 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Youichi Ogawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Hauptthemen laut MEDLINE: Psoriasis, Peroxidase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Generalized pustular psoriasis (GPP) is a recurrent and sometimes life‐threatening sterile pustular disease. Because interleukin (IL)‐36 is the central cytokine in disease formation, spesolimab, which interferes with IL‐36 receptor signaling, is highly effective. Here, we report a patient with GPP with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab. Although spesolimab showed excellent clinical efficacy in resolving pre‐existing pustules and erythema, it did not suppress the emergence of new pustules and erythema, which did not decrease the peripheral blood neutrophil count, therefore bimekizumab, an anti‐IL‐17A/IL‐17F antibody, was administered after the second spesolimab infusion, which resolved the pustules and erythema. We discuss the possible reasons for the resistance mechanism to spesolimab.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Youichi Ogawa, Takuya Takeichi, Takashi Okamoto, Hiroshi Mitsui, Masashi Akiyama
Zitieren
APA
Ogawa, Y., Maejima, E., Takeichi, T., Okamoto, T., Mitsui, H., Shimada, S., Akiyama, M., & Kawamura, T. (2025). Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17464
Vancouver
Ogawa Y, Maejima E, Takeichi T, Okamoto T, Mitsui H, Shimada S, et al. Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17464
BibTeX
@article{Ogawa2025,
author = {Ogawa, Youichi and Maejima, Eri and Takeichi, Takuya and Okamoto, Takashi and Mitsui, Hiroshi and Shimada, Shinji and Akiyama, Masashi and Kawamura, Tatsuyoshi},
title = {Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17464}
}
EUVIMED